(Q44193642)

30 November 2017

title

Differential in vitro hepatotoxicity of troglitazone and rosiglitazone among cryopreserved human hepatocytes from 37 donors (English)

1 reference

30 November 2017

0 references

1 reference

1 reference

7

1 reference

30 November 2017

Scott Lloyd

1

1 reference

30 November 2017

Michael J Hayden

2

1 reference

30 November 2017

Yumiko Sakai

3

1 reference

30 November 2017

Andrew Fackett

4

1 reference

30 November 2017

Paul M Silber

5

1 reference

30 November 2017

Nicola J Hewitt

6

1 reference

30 November 2017

publication date

1 November 2002

1 reference

Chemico-biological Interactions

30 November 2017

published in

1 reference

30 November 2017

volume

142

1 reference

30 November 2017

issue

1-2

1 reference

30 November 2017

page(s)

57-71

1 reference

Effects of troglitazone on cellular differentiation, insulin signaling, and glucose metabolism in cultured human skeletal muscle cells

30 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0009-2797%2802%2900054-6

Thiazolidinediones in the treatment of insulin resistance and type II diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-2797%2802%2900054-6

PPAR-gamma: adipogenic regulator and thiazolidinedione receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-2797%2802%2900054-6

Troglitazone and liver function abnormalities: lessons from a prescription event monitoring study and spontaneous reporting

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-2797%2802%2900054-6

7 January 2021

FDA reviews troglitazone

1 reference

https://api.crossref.org/works/10.1016%2FS0009-2797%2802%2900054-6

Hepatic failure in a patient taking rosiglitazone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-2797%2802%2900054-6

Hepatocellular injury in a patient receiving rosiglitazone. A case report

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-2797%2802%2900054-6

Toxic effect of troglitazone on cultured rat hepatocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-2797%2802%2900054-6

Cholestatic potential of troglitazone as a possible factor contributing to troglitazone-induced hepatotoxicity: in vivo and in vitro interaction at the canalicular bile salt export pump (Bsep) in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-2797%2802%2900054-6

Optimization of cryopreservation procedures for rat and human hepatocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-2797%2802%2900054-6

Cryopreserved human hepatocytes: characterization of drug-metabolizing enzyme activities and applications in higher throughput screening assays for hepatotoxicity, metabolic stability, and drug-drug interaction potential

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-2797%2802%2900054-6

Determining glutathione and glutathione disulfide using the fluorescence probe o-phthalaldehyde

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-2797%2802%2900054-6

10.1016/S0009-2797(02)00054-6

7 January 2021

Identifiers

DOI

1 reference

30 November 2017

1 reference